Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing oxygen targets with different oximeters for better oxygen flow management

Official title: Comparison of Two Oxygenation Targets With Two Different Oximeters - Impact on Oxygen Flow Rates and Oxygenation

Run by Laval University · NCT05590130 · Data updated 2026-11-12

This study tests whether using different types of oximeters can help manage oxygen flow better for patients recovering from heart surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorLaval University
Academic / other
Locations1 site (Québec, Quebec)
StatusRecruiting
StartedNovember 16, 2022
Main results expectedJune 2027
Study endsDecember 2027
Registry record updatedNovember 5, 2026
Trial IDNCT05590130 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are admitted to a postoperative cardiac surgery intensive care unit and require conventional oxygen therapy.

Probably not a fit

Patients who are unable to provide a SpO2 signal with the oximeter or have conditions like methemoglobinemia or are in isolation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the impact of two different oximeters, Nonin and Philips, on oxygen flow rates and oxygenation targets in patients recovering from cardiac surgery. Participants will be assigned to different oximeters and SpO2 targets (90% and 94%) in a randomized manner, with arterial gas samples collected to assess oxygenation levels. The goal is to determine how the choice of oximeter and target saturation affects the required oxygen flow rates. This could lead to more effective oxygen management in postoperative care.

Why it matters

Potential benefit: If successful, this study could improve oxygen management strategies, potentially reducing the risk of oxygen toxicity and respiratory failure in postoperative patients.

How similar studies have gone: While there have been studies on oximeter accuracy, this specific comparison of oxygen targets and their impact on flow rates is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ≥ 18 years of age
* Patients admitted to postoperative cardiac surgery intensive care unit
* Presence of an arterial catheter Specific for the extubate patient
* Ongoing on conventional oxygen therapy at moderate flow (up to a maximum of 5L/min) with SpO2 between 88 and 100% with the usual oximeter and nasal cannula.
* SpO2 \< 92% ambient air Specific for the intubate patient FiO2 \<= 0.60 with SpO2 between 88 and 100% with usual oximeter SpO2 \< 92% with FiO2 0.21

Exclusion Criteria:

* No SpO2 signal with oximeter in use
* False nails or nail polish
* Methemoglobinemia \>0.015 on last available arterial gas
* Patient in isolation (multi-resistant bacteria, C-Difficile, SARS-CoV-2 ...) Specific for the extubate patient
* Expected to use another respiratory support within one hour of inclusion (NIV or nasal high flow oxygen) Planned extubation within one hour of inclusion

Where it's running

  • Institut Universitaire de Cardiologie et de Pneumologie de Québec
    Québec, Quebec, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.